(Q94863286)

English

Ofatumumab, a second-generation anti-CD20 monoclonal antibody, for the treatment of lymphoproliferative and autoimmune disorders

scientific article published in April 2009

In more languages

edit

Statements

instance of

scholarly article

1 reference

stated in

Europe PubMed Central

PubMed publication ID

19335277

reference URL

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19335277%20AND%20SRC:MED&resulttype=core&format=json

retrieved

20 May 2020

title

Ofatumumab, a second-generation anti-CD20 monoclonal antibody, for the treatment of lymphoproliferative and autoimmune disorders (English)

1 reference

stated in

Europe PubMed Central

PubMed publication ID

19335277

reference URL

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19335277%20AND%20SRC:MED&resulttype=core&format=json

20 May 2020

1 reference

1

1 reference

stated in

Europe PubMed Central

PubMed publication ID

19335277

reference URL

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19335277%20AND%20SRC:MED&resulttype=core&format=json

retrieved

20 May 2020

author name string

Cannon Milani

series ordinal

2

1 reference

stated in

Europe PubMed Central

PubMed publication ID

19335277

reference URL

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19335277%20AND%20SRC:MED&resulttype=core&format=json

retrieved

20 May 2020

Daniel Mendez-Allwood

series ordinal

3

1 reference

stated in

Europe PubMed Central

PubMed publication ID

19335277

reference URL

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19335277%20AND%20SRC:MED&resulttype=core&format=json

retrieved

20 May 2020

publication date

1 April 2009

1 reference

stated in

Europe PubMed Central

PubMed publication ID

19335277

reference URL

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19335277%20AND%20SRC:MED&resulttype=core&format=json

retrieved

20 May 2020

published in

Expert Opinion on Investigational Drugs

1 reference

stated in

Europe PubMed Central

PubMed publication ID

19335277

reference URL

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19335277%20AND%20SRC:MED&resulttype=core&format=json

retrieved

20 May 2020

volume

18

1 reference

stated in

Europe PubMed Central

PubMed publication ID

19335277

reference URL

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19335277%20AND%20SRC:MED&resulttype=core&format=json

retrieved

20 May 2020

issue

4

1 reference

stated in

Europe PubMed Central

PubMed publication ID

19335277

reference URL

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19335277%20AND%20SRC:MED&resulttype=core&format=json

retrieved

20 May 2020

page(s)

491-500

1 reference

stated in

Europe PubMed Central

PubMed publication ID

19335277

reference URL

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19335277%20AND%20SRC:MED&resulttype=core&format=json

retrieved

20 May 2020

Identifiers

DOI

10.1517/13543780902832679

1 reference

stated in

Europe PubMed Central

PubMed publication ID

19335277

reference URL

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19335277%20AND%20SRC:MED&resulttype=core&format=json

retrieved

20 May 2020

PubMed publication ID

19335277

1 reference

stated in

Europe PubMed Central

PubMed publication ID

19335277

reference URL

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19335277%20AND%20SRC:MED&resulttype=core&format=json

(Q94863286)

Ofatumumab, a second-generation anti-CD20 monoclonal antibody, for the treatment of lymphoproliferative and autoimmune disorders

Statements

Identifiers

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)